APA

van den Heuvel M. M., Uyterlinde W., Vincent A. D., de Jong J., Aerts J., Koppe F., Knegjens J., Codrington H., Kunst P. W. E., Dieleman E., Verheij M. & Belderbos J. (20150521). Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chicago

van den Heuvel Michel M, Uyterlinde Wilma, Vincent Andrew D, de Jong Jeroen, Aerts Joachim, Koppe Frederike, Knegjens Joost, Codrington Henk, Kunst Peter W E, Dieleman Edith, Verheij Marcel and Belderbos José. 20150521. Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Harvard

van den Heuvel M. M., Uyterlinde W., Vincent A. D., de Jong J., Aerts J., Koppe F., Knegjens J., Codrington H., Kunst P. W. E., Dieleman E., Verheij M. and Belderbos J. (20150521). Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MLA

van den Heuvel Michel M, Uyterlinde Wilma, Vincent Andrew D, de Jong Jeroen, Aerts Joachim, Koppe Frederike, Knegjens Joost, Codrington Henk, Kunst Peter W E, Dieleman Edith, Verheij Marcel and Belderbos José. Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 20150521.